Mood Disorders News

In this video, Manpreet Kaur Singh, MD, MS, an associate professor of psychiatry and behavioral sciences at Stanford University, spoke with Healio about her presentation on diagnosing and treating bipolar disorder at the 2022 NEI Congress.

The COVID-19 pandemic had a significant negative impact on mental health and accelerated brain maturation in adolescents, according to a recent study.

There is a close relationship between psychiatric disorders, psychotropic prescription and treatment compliance, and the risk for complicated appendicitis, researchers reported in BMC Psychiatry.

Childhood poverty was associated with increases in externalizing problems, but not internalizing, over time in early adolescence, researchers reported in JAMA Network Open.

In this video, Manpreet Kaur Singh, MD, MS, spoke with Healio about research being conducted in precision medicine to treat mood disorders that she discussed during a presentation at the 2022 NEI Congress.

Manpreet Kaur Singh, MD, MS, spoke with Healio about her presentation on personalized treatment selection for mood disorders using biotypes at this year’s NEI Congress.

Videra Health has announced a partnership with Signature Healthcare Services to improve the post-discharge follow-up experience by using AI-assisted video assessments for those with behavioral health issues.

Digital health solutions company Twill has announced a partnership with e-Psychiatry, a telepsychiatry and teletherapy service, that it says will provide increased human and digital mental health support for patients.

Treatment with suvorexant and lemborexant may be effective for preventing delirium in critically ill adult patients, according to a study published in the Journal of Clinical Psychiatry.

Lusaris Therapeutics announced its launch with $60 million in Series A financing to advance LSR-1019, a sublingual formulation of 5-MeO-DMT for patients with treatment-resistant depression and other severe neuropsychiatric disorders.